18 kinds! National Health Commission issued the first batch of key national high-value medical consumables governance list
Release date: 2020-01-14 Views: 0
Today (January 14), the National Health Commission issued the "First Batch of National Key Management Lists of High-Value Medical Consumables", and a total of 18 types of consumables were included in the key management list.
The health and health committees of provinces, autonomous regions, municipalities and Xinjiang Production and Construction Corps:
In order to strengthen the standardized management of high-value medical consumables and clarify the scope of governance, in accordance with the requirements of the "Reform Program for Governing High-value Medical Consumables" (Guobanfa  No. 37) issued by the General Office of the State Council, our committee organized the development of the "first batch of national The List of Key Management Items for High-Value Medical Consumables (hereinafter referred to as the "List") is now being issued to you. Provincial health and administrative departments are requested to increase the number of breeds as appropriate based on the actual situation of each place, to form a provincial list, and to guide the medical institutions within their jurisdiction to formulate a list of medical institutions. Local health and administrative departments at all levels and various types of medical institutions must strictly implement the relevant requirements of the "Administrative Measures for Medical Consumables in Medical Institutions (Trial)", strengthen the management of medical consumables, and do a good job in accordance with the requirements for the reform of high-value medical consumables. jobs.
Attachment: the first batch of national key management lists of high-value medical consumables
- Basic introduction of Heilongjiang Hexiang Pharmaceutical Co., Ltd.
- How to contact Bermuda Medical (Shanghai) Regenerative Medicine Technology Co., Ltd.
- Shandong Dongfang Huiyi Health Industry Co., Ltd.
- Brief introduction of Zaozhuang Yinhai Pharmaceutical Co., Ltd.
- Contact information of Shandong Dongfang Huiyi Health Industry Co., Ltd.
- Introduction of Bermoudi (Shanghai) Regenerative Medicine Technology Co., Ltd.
- Nature子刊：2020年FDA可能批准的新药 1. Nature issue: FDA may approve new drugs in 2020
- “即用型”CAR-T疗法：权宜之计还是未来的发展方向？ 2. "Ready-to-use" CAR-T therapy: an expedient or future direction?
- 2019年全球新上市的重磅创新药盘点 3. Inventory of blockbuster innovative medicines listed globally in 2019
- 2019年12月全球批准新药概况 4. Global Approval of New Drugs in December 2019
- 18种！ 5. 18 types! National Health Commission issued the first batch of key national high-value medical consumables governance list
- 国家药监局发文为亚硝胺类杂质的控制提供指导 6.SFDA issued a document to provide guidance for the control of nitrosamine impurities
- 福建针对未过一致性评价药品开展带量采购 7.Fujian carries out volume procurement for drugs that have not been consistently evaluated